Test promises low cost BRCA mutation breast screening
This article was originally published in Clinica
Executive Summary
A US team has developed an innovative and inexpensive approach for detecting mutations in the BRCA1 and BRCA2 breast and ovarian cancer susceptibility genes that involves testing cells from cheek swabs. The new test, which is based on an immunoassay, could help reduce the number of women who need to undergo more costly gene sequencing techniques.